Flavonoids mixture ( @entity23663 , @entity32925 , XXXX ) in the treatment of acute @entity6713 : a prospective, randomized, triple-blind, controlled trial.

@entity1 @entity32925 @entity1697 @entity548 @entity4 @entity1443 @entity6713 @entity158 @entity35085 @entity715 @entity23663 @entity3096
BACKGROUND: The role of a mixture of phlebotonics in the treatment of acute @entity6713 crisis is investigated to test their efficacy. METHODS: One hundred and thirty-four consecutive @entity1 with an acute @entity6713 recruited in five colorectal units entered the study. Sixty-six of them were randomized to receive a mixture of @entity23663 , @entity32925 and @entity35085 (group A), and 68 a placebo (group B). The main symptoms, the use of @entity1697 and the Bristol scale score were recorded at each scheduled visit and compared using both Student's t test for independent samples and the ANOVA models for repeated measures. The presence of @entity4 , prolapse and @entity715 were also recorded and compared using the Chi-square test. Furthermore, the trend of proportions during the time of the evaluations was assessed by the Chi-square test for linear trend. RESULTS: @entity158 , @entity548 and the proportion of @entity1 who reported persistence of @entity4 and @entity715 decreased significantly after 12  days of treatment in group A. After 6  days, the number of @entity1443 tablets taken by @entity1 in group A was significantly lower than the amount of @entity3096 mixture. CONCLUSIONS: The use of a mixture of @entity23663 , @entity32925 and @entity35085 is a safe and effective mean of managing symptoms of acute @entity6713 . Furthermore, in @entity1 receiving treatment, there was faster control and lower persistence of @entity4 and @entity715 .
